Funder
IV
Merck Sharp & Dohme Corp.
Merck & Co., Inc.
Reference19 articles.
1. Keytruda [package insert],2017
2. Pembrolizumab for the treatment of non-small-cell lung cancer;Garon;N Engl J Med,2015
3. Pembrolizumab: role of modeling and simulation in bringing a novel immunotherapy to patients with melanoma;de Greef;CPT Pharmacometrics Syst Pharmacol,2017
4. Evaluation of dosing strategy for pembrolizumab for oncology indications;Freshwater;J Immunother Cancer,2017
5. Providing clinical evidence of effectiveness for human drug and biological products,1998
Cited by
117 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献